Skip to content
10-Q

Quarterly Report

GB SCIENCES INC

0001437749-24-003766

← back to feed
Filed
Feb 12, 2024 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2024 · Feb 12, 2024 406.07M sh
Cash And Equivalents Q3 2024 · Dec 31, 2023 $17.46K
Cash And Equivalents Q3 2024 · Mar 31, 2023 $109.91K
Stockholders Equity Q3 2024 · Dec 31, 2023 −$4.85M
Stockholders Equity Q3 2024 · Mar 31, 2023 −$4.41M
Current Liabilities Q3 2024 · Dec 31, 2023 $4.92M
Current Liabilities Q3 2024 · Mar 31, 2023 $4.76M
Total Liabilities Q3 2024 · Dec 31, 2023 $4.99M
Total Liabilities Q3 2024 · Mar 31, 2023 $4.76M
Current Assets Q3 2024 · Dec 31, 2023 $147.11K
Current Assets Q3 2024 · Mar 31, 2023 $309.5K
Total Assets Q3 2024 · Dec 31, 2023 $147.11K
Total Assets Q3 2024 · Mar 31, 2023 $352.32K
Operating Cash Flow Q3 2024 · Dec 31, 2022 −$1.31M
Eps Basic Q3 2024 · Dec 31, 2022 $0.00
Eps Basic Q3 2024 · Dec 31, 2022 $0.00
Sga Expense Q3 2024 · Dec 31, 2022 $407.3K
Sga Expense Q3 2024 · Dec 31, 2022 $1.14M
Net Income Q3 2024 · Dec 31, 2022 −$448.77K
Net Income Q3 2024 · Dec 31, 2022 −$1.26M
Operating Income Q3 2024 · Dec 31, 2022 −$407.3K
Operating Income Q3 2024 · Dec 31, 2022 −$1.14M
Gross Profit Q3 2024 · Dec 31, 2022 $0
Gross Profit Q3 2024 · Dec 31, 2022 $0
Cost Of Revenue Q3 2024 · Dec 31, 2022 $0
Cost Of Revenue Q3 2024 · Dec 31, 2022 $0
Revenue Q3 2024 · Dec 31, 2022 $0
Revenue Q3 2024 · Dec 31, 2022 $0